Cargando…
Iloprost as an acute kidney injury-triggering agent in severely atherosclerotic patients
BACKGROUND: Iloprost, a stable prostacyclin analog, is used as a rescue therapy for severe peripheral arterial disease (PAD). It has systemic vasodilatory and anti-aggregant effects, with severe vasodilatation potentially causing organ ischaemia when severe atherosclerosis is the underlying cause. I...
Autores principales: | Uyar, Mehtap Erkmen, Yucel, Piril, Ilin, Sena, Bal, Zeynep, Yildirim, Saliha, Uyar, Ahmet Senol, Akay, Tankut, Tutal, Emre, Sezer, Siren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Clinics Cardive Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101430/ https://www.ncbi.nlm.nih.gov/pubmed/27841898 http://dx.doi.org/10.5830/CVJA-2015-051 |
Ejemplares similares
-
Long-Term Oral Nutrition Supplementation Improves Outcomes in Malnourished Patients With Chronic Kidney Disease on Hemodialysis
por: Sezer, Siren, et al.
Publicado: (2014) -
New-Onset Diabetes and Glucose Regulation Are Significant Determinants of Left Ventricular Hypertrophy in Renal Transplant Recipients
por: Sezer, Siren, et al.
Publicado: (2015) -
Factors Influencing Hemoglobin Variability and Its Association with Mortality in Hemodialysis Patients
por: Bal, Zeynep, et al.
Publicado: (2018) -
rHuEPO Hyporesponsiveness and Related High Dosages Are Associated with Hyperviscosity in Maintenance Hemodialysis Patients
por: Erkmen Uyar, Mehtap, et al.
Publicado: (2013) -
The effect of iloprost and sildenafil, alone and in combination, on myocardial ischaemia and nitric oxide and irisin levels
por: Suna, Aydin, et al.
Publicado: (2017)